Patient living with hereditary ATTR Amyloidosis
1 Views
administrator
07/08/23
Rick, a man in his 60's, talks about living with the rare disease, hereditary ATTR amyloidosis, a rapidly progressive and life-threatening disease, and finding new hope in Alnylam's new treatment, ONPATTRO™ which has just been approved by the FDA in August 2018.
Visit www.hpr.fm for more health-related stories and interviews.
-
Category
Show more
Facebook Comments
No comments found